BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17189202)

  • 1. Angiotensin in the kidney: a key to understanding hypertension?
    Steckelings UM; Rettig R; Unger T
    Cell Metab; 2007 Jan; 5(1):7-8. PubMed ID: 17189202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney.
    Crowley SD; Gurley SB; Herrera MJ; Ruiz P; Griffiths R; Kumar AP; Kim HS; Smithies O; Le TH; Coffman TM
    Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17985-90. PubMed ID: 17090678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal AT 1 receptors and hypertension.
    Ruilope LM
    Nephrol Dial Transplant; 2007 Aug; 22(8):2136-7. PubMed ID: 17412699
    [No Abstract]   [Full Text] [Related]  

  • 4. Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy.
    Jaffré F; Bonnin P; Callebert J; Debbabi H; Setola V; Doly S; Monassier L; Mettauer B; Blaxall BC; Launay JM; Maroteaux L
    Circ Res; 2009 Jan; 104(1):113-23. PubMed ID: 19023134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquisition of brain Na sensitivity contributes to salt-induced sympathoexcitation and cardiac dysfunction in mice with pressure overload.
    Ito K; Hirooka Y; Sunagawa K
    Circ Res; 2009 Apr; 104(8):1004-11. PubMed ID: 19299647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In hypertension, the kidney rules.
    Crowley SD; Coffman TM
    Curr Hypertens Rep; 2007 Apr; 9(2):148-53. PubMed ID: 17442227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension.
    Letavernier E; Perez J; Bellocq A; Mesnard L; de Castro Keller A; Haymann JP; Baud L
    Circ Res; 2008 Mar; 102(6):720-8. PubMed ID: 18258859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure.
    Yamamoto E; Kataoka K; Shintaku H; Yamashita T; Tokutomi Y; Dong YF; Matsuba S; Ichijo H; Ogawa H; Kim-Mitsuyama S
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2569-75. PubMed ID: 17932313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The angiotensin type 1 receptor antagonist valsartan attenuates pathological ventricular hypertrophy induced by hyperhomocysteinemia in rats.
    Kassab S; Garadah T; Abu-Hijleh M; Golbahar J; Senok S; Wazir J; Gumaa K
    J Renin Angiotensin Aldosterone Syst; 2006 Dec; 7(4):206-11. PubMed ID: 17318789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular signaling mediated by angiotensin II type 1A receptor blockade leading to attenuation of renal dysfunction-associated heart failure.
    Li Y; Takemura G; Okada H; Miyata S; Maruyama R; Esaki M; Kanamori H; Li L; Ogino A; Ohno T; Kondo T; Nakagawa M; Minatoguchi S; Fujiwara T; Fujiwara H
    J Card Fail; 2007 Mar; 13(2):155-62. PubMed ID: 17395057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotective effects of granulocyte colony-stimulating factor in angiotensin II-induced cardiac remodelling.
    Jia N; Dong P; Huang Q; Jin W; Zhang J; Dai Q; Liu S
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):262-6. PubMed ID: 18785976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin type 1 receptor blockade prevents cardiac remodeling in mice with pregnancy-associated hypertension.
    Sakairi A; Ishida J; Honjo K; Inaba S; Nakamura S; Sugiyama F; Yagami K; Fukamizu A
    Hypertens Res; 2008 Dec; 31(12):2165-75. PubMed ID: 19139606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up- and down-regulation of angiotensin II AT1-A and AT1-B receptors in afferent and efferent rat kidney arterioles.
    Razga Z; Nyengaard JR
    J Renin Angiotensin Aldosterone Syst; 2008 Dec; 9(4):196-201. PubMed ID: 19126659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension.
    Sendra J; Llorente-Cortés V; Costales P; Huesca-Gómez C; Badimon L
    Cardiovasc Res; 2008 Jun; 78(3):581-9. PubMed ID: 18281370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldosterone-induced activation of signaling pathways requires activity of angiotensin type 1a receptors.
    Lemarié CA; Simeone SM; Nikonova A; Ebrahimian T; Deschênes ME; Coffman TM; Paradis P; Schiffrin EL
    Circ Res; 2009 Oct; 105(9):852-9. PubMed ID: 19762686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant adeno-associated virus-mediated delivery of antisense angiotensin II receptor 1 gene attenuates hypertension development.
    Li XG; Yan JT; Xu XZ; Wang JN; Cheng LM; Wang T; Zuo P; Wang DW
    Acta Pharmacol Sin; 2007 Nov; 28(11):1737-45. PubMed ID: 17959024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered regulation of renal interstitial hydrostatic pressure and the renal renin-angiotensin system in the absence of atrial natriuretic peptide.
    O'Tierney PF; Komolova M; Tse MY; Adams MA; Pang SC
    J Hypertens; 2008 Feb; 26(2):303-11. PubMed ID: 18192845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulator of G protein signalling 2 ameliorates angiotensin II-induced hypertension in mice.
    Hercule HC; Tank J; Plehm R; Wellner M; da Costa Goncalves AC; Gollasch M; Diedrich A; Jordan J; Luft FC; Gross V
    Exp Physiol; 2007 Nov; 92(6):1014-22. PubMed ID: 17644703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac BNP gene activation by angiotensin II in vivo.
    Majalahti T; Suo-Palosaari M; Sármán B; Hautala N; Pikkarainen S; Tokola H; Vuolteenaho O; Wang J; Paradis P; Nemer M; Ruskoaho H
    Mol Cell Endocrinol; 2007 Jul; 273(1-2):59-67. PubMed ID: 17587490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue kallikrein is involved in the cardioprotective effect of AT1-receptor blockade in acute myocardial ischemia.
    Messadi-Laribi E; Griol-Charhbili V; Pizard A; Vincent MP; Heudes D; Meneton P; Alhenc-Gelas F; Richer C
    J Pharmacol Exp Ther; 2007 Oct; 323(1):210-6. PubMed ID: 17636004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.